SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 24, 2003
BRISTOL-MYERS SQUIBB COMPANY
(Exact Name of Registrant as Specified in its Charter)
(State or Other Jurisdiction
(Commission File Number)
345 Park Avenue
New York, NY 10154
(Address of Principal Executive Office)
Registrant's telephone number, including area code: (212) 546-4000
Item 7. Financial Statements and Exhibit
Press Release of Bristol-Myers Squibb Company dated July 24, 2003, reporting Bristol-Myers Squibb's financial results for the second quarter of 2003.
Item 9. Regulation FD Disclosure
Incorporated by reference is a press release issued by the Registrant on July 24, 2003 regarding earnings for the second quarter of 2003, attached as Exhibit 99.1. This information is being furnished pursuant to Item 12Results of Operations and Financial Condition on Form 8-K and is being presented under Item 9 on Form 8-K in accordance with interim guidance issued by the Securities and Exchange Commission in Release Nos. 33-8216 and 34-47583. This information is not deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934 and is not incorporated by reference into any Securities Act registration statements.
Under the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|BRISTOL-MYERS SQUIBB COMPANY|
By: /s/ SANDRA LEUNG
Date: July 24, 2003
Press release issued July 24, 2003 regarding earnings for second quarter of 2003